Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FDG-PET Based Chemotherapy Selection for Metastatic NSCLC
NCT00564733Phase 2Completed
- Sponsor
- University of Washington
- Start
- Oct 2007
- Primary completion
- Sep 2011
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin, docetaxel, gemcitabine in non-small cell lung cancer (NSCLC), sponsored by University of Washington. Started Oct 2007; status: completed.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatindocetaxelgemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00564733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564733.